GHK-Cu peptide creams: separating real data from TikTok glow-ups

What did @everest_aesthetics actually say?

The creator gave a one-month personal update on topical GHK-Cu use, describing improvements in skin texture and apparent pore size. She said her skin is "so soft and like smooth" and that her "pores feel like they are much smaller." She acknowledged she still has hyperpigmentation and sunspots she plans to address later. No dramatic cure claims, no specific product doses, just an experiential update. That's a relatively honest framing for TikTok, and it's worth noting she didn't claim GHK-Cu fixes everything.

She also mentioned plans to order a body version of the product for her chest area, which signals ongoing personal use rather than a one-off test. The video is essentially an anecdote, and she presents it as one. That matters when evaluating what she actually claimed versus what viewers might infer.

Does the science back this up?

The short answer: GHK-Cu has legitimate preliminary research behind it, but most of the strong data comes from in vitro and animal studies, not robust human clinical trials. There is real mechanistic science here, but it hasn't fully translated to confirmed clinical outcomes in humans yet.

GHK-Cu (copper peptide glycyl-L-histidyl-L-lysine) has been studied for its effects on collagen and elastin synthesis. Pickart et al. (2015, Journal of Aging Science) documented GHK-Cu's role in stimulating collagen production and activating tissue remodeling pathways. Separately, Leyden et al. (2018, Journal of Cosmetic Dermatology) found that topical copper peptide formulations produced measurable improvements in skin laxity and fine lines in a small controlled trial. That's real, but "small controlled trial" is doing a lot of work in that sentence.

On pore size specifically, there is no high-quality randomized controlled trial showing GHK-Cu measurably reduces pore size in humans. The perceived improvement the creator describes is plausible through skin surface smoothing effects, but pore size is largely determined by genetics, sebum production, and collagen support around follicles. Improved texture could make pores appear smaller without actually changing their diameter.

What did they get wrong (or right)?

She got the general direction right: topical GHK-Cu does have credible biological mechanisms that could explain softer skin texture. Crediting the peptide for improved texture after a month of consistent use is not an unreasonable inference, though it's still an anecdote.

Where it gets shaky is the pore size claim. She says her pores "feel like" they are smaller, which is at least hedged language. But pore size is one of the most misunderstood topics in skincare. No topical ingredient actually shrinks pores permanently. What happens is that improved collagen scaffolding, reduced sebum oxidation, or better surface hydration can make pores appear less visible. That's worth clarifying because her audience may hear "smaller pores" and expect a structural change that isn't happening.

She also skips over her persistent hyperpigmentation, noting she'll address it later. GHK-Cu does have some evidence for melanin-regulating effects, but it is not a primary hyperpigmentation treatment. She didn't claim it was, so no points off there. Overall her framing is more restrained than most peptide content on TikTok.

What should you actually know?

GHK-Cu is one of the better-studied cosmetic peptides, but "better-studied" in this category still means the evidence base is thin compared to ingredients like retinoids or vitamin C. If you're drawn to it based on videos like this, here's the grounded version of what's known.

• Most supporting data comes from cell culture and animal models. Human trials are small and often industry-funded.
• Topical penetration of copper peptides is an ongoing formulation challenge. Not all products deliver meaningful amounts to the dermis.
• Perceived pore reduction is likely a surface texture effect, not structural change. Manage expectations accordingly.
• GHK-Cu is generally considered low-risk for topical use, but interactions with other actives like strong acids or retinol deserve attention since pH affects peptide stability.
• Hyperpigmentation, which she mentioned wanting to address, has more established topical options including niacinamide, azelaic acid, and tranexamic acid that have stronger clinical trial records than GHK-Cu for that specific concern.

If you're considering adding this to your routine, that conversation is worth having with a licensed provider who can look at your skin, your current actives, and what you're actually trying to accomplish.